ArticleMikrochimica acta2025
An AND-gate DNA walker sensing microRNA and flap endonuclease 1.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Precise and sensitive detection of cancer biomarkers is essential for early diagnosis and effective treatment. However, most existing sensing strategies rely on single targets, which may lack the specificity required for accurate disease diagnosis. To address this limitation, we propose an AND-gate logic DNA walker capable of simultaneously detecting two distinct types of biomarkers: miRNA-21 and flap endonuclease 1 (FEN1). This DNA walker employs a capture strand immobilized on AuNPs to bind miRNA-21, which then hybridizes with a fluorescent-tagged track strand to form a structure recognizable by FEN1. Upon FEN1 cleavage, fluorescence signals are released, enabling highly sensitive detection. The detection limits were 23.3 pM for miRNA-21 and 0.097 pg/μL for FEN1. The DNA walker demonstrates exceptional performance in intracellular in situ imaging of these biomarkers, offering a powerful tool for cancer diagnosis and investigation of disease mechanisms. This AND-gate DNA walker serves as a model for constructing multi-target detection systems with high specificity and sensitivity.
Indexed as
Identifiers
40848127What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.